Evaluating phenotype and genotype of drug-resistant strains in herpesviruses

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 18, Issue 2, 2001, Pages 155-167

  Andrei, G ^a   Fiten, P ^a   De Clercq, E ^a   Snoeck, R ^a   Opdenakker, G ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Drug resistant herpesvirus; HSV 1 DNA polymerase; Phenotyping genotyping

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; CIDOFOVIR; DNA POLYMERASE; FOSCARNET; GANCICLOVIR; PLASMID DNA;

ANTIBIOTIC RESISTANCE; ARTICLE; CYTOMEGALOVIRUS; GENE MUTATION; GENE TARGETING; GENOTYPE; HERPES; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; STRAIN DIFFERENCE; VARICELLA ZOSTER VIRUS;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; CYTOMEGALOVIRUS; DNA MUTATIONAL ANALYSIS; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, MULTIPLE, VIRAL; ESCHERICHIA COLI; EXODEOXYRIBONUCLEASES; GENOTYPE; HERPESVIRUS 3, HUMAN; MICROBIAL SENSITIVITY TESTS; MUTATION; PHENOTYPE; PLAQUE ASSAY; SIMPLEXVIRUS; VERO CELLS; VIRAL PROTEINS;

EID: 0034933726     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1385/MB:18:2:155     Document Type: Article

References (14)

1. "The end of innocence" revisited: Resistance of herpesviruses to antiviral drugs
2. Anonymous Drug resistance in cytomegalovirus: Current knowledge and implications for patient management
3. The implicatons of resistance to antiviral agents for herpesvirus drug targets and drug therapy
4. Nucleosides and foscarnet - Mechanisms
5. Nucleosides and foscarnet - Clinical aspects
6. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine (HPMPC)
7. Cidofovir, a new agent with potent anti-herpesvirus activity
8. Laboratory studies of herpes simplex virus strains resistant to acyclovir
9. Susceptibilities of several drug-resistant herpes simplex virus type 1 strains to alternative antiviral compounds
10. Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro
11. Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene
12. Phenotypic resistance of herpes simplex virus type 1 strains selected in vitro with antiviral compounds and combinations thereof
13. Human brain tumour cell lines as cell substrate to demonstrate sensitivity/resistance of herpes simplex virus types 1 and 2 to nucleoside analogues